Welcome Wondros Family and
Friends! We are beta testing and need
your help improving this product.
Share Feedback
Locations
31 locations
Status
Recruiting
Study Type
Interventional
Timeframe
At Month 3
Accepts healthy volunteers
No
Age
18 Years +
Gender
All
Placebo Arm
No
Locations
1 locations
Status
Active, not recruiting
Study Type
Interventional
Timeframe
8 weeks
Accepts healthy volunteers
No
Age
18 Years - 45 Years
Gender
Female
Placebo Arm
Yes
Locations
14 locations
Status
Recruiting
Study Type
Interventional
Timeframe
up to 24 months
Accepts healthy volunteers
No
Age
18 Years +
Gender
All
Placebo Arm
No
Locations
2 locations
Status
Recruiting
Study Type
Interventional
Timeframe
4 weeks
Accepts healthy volunteers
No
Age
18 Years - 65 Years
Gender
All
Placebo Arm
No
Locations
1 locations
Status
Completed
Study Type
Observational
Timeframe
At day 1 of study participation
Accepts healthy volunteers
No
Age
18 Years +
Gender
All
Placebo Arm
No
Locations
7 locations
Status
Active, not recruiting
Study Type
Interventional
Timeframe
Baseline up to 12 months after last participant enrolled in Cohort
Accepts healthy volunteers
No
Age
18 Years +
Gender
All
Placebo Arm
No
Locations
10 locations
Status
Recruiting
Study Type
Interventional
Timeframe
Until disease progression (up to 4 years)
Accepts healthy volunteers
No
Age
18 Years +
Gender
All
Placebo Arm
No
Locations
2 locations
Status
Recruiting
Study Type
Interventional
Timeframe
comparasion in EMU for 3-14 days period, where patients are hospitalized.
Accepts healthy volunteers
No
Age
18 Years - 75 Years
Gender
All
Placebo Arm
No
Locations
1 locations
Status
Active, not recruiting
Study Type
Observational
Timeframe
11 days
Accepts healthy volunteers
No
Age
18 Years - 65 Years
Gender
All
Placebo Arm
No
Locations
17 locations
Status
Completed
Study Type
Interventional
Timeframe
Up to Day 30
Accepts healthy volunteers
No
Age
12 Months - 15 Months
Gender
All
Placebo Arm
No
Locations
1 locations
Status
Withdrawn
Study Type
Observational
Timeframe
15 days
Accepts healthy volunteers
No
Age
18 Years +
Gender
All
Placebo Arm
No
Locations
1 locations
Status
Completed
Study Type
Interventional
Timeframe
Screening to enrollment (Week 1)
Accepts healthy volunteers
No
Age
18 Years +
Gender
All
Placebo Arm
No
Locations
6 locations
Status
Recruiting
Study Type
Interventional
Timeframe
2 years
Accepts healthy volunteers
No
Age
18 Years +
Gender
All
Placebo Arm
No
Locations
9 locations
Status
Recruiting
Study Type
Interventional
Timeframe
From randomization until disease progression or loss of clinical benefit (up to approximately 3-5 years)
Accepts healthy volunteers
No
Age
18 Years +
Gender
All
Placebo Arm
No
Locations
1 locations
Status
Recruiting
Study Type
Interventional
Timeframe
Measured at 3-months post-screening
Accepts healthy volunteers
No
Age
18 Years +
Gender
All
Placebo Arm
No
A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema
Part A of the study is conducted to select the THR-149 dose level. Part B of the study is conducted to assess the efficacy and safety of the selec...
Sponsored by:
Oxurion
Trial Location:
King's College Hospital NHS Foundation Trust, London, SE5 9RS, United Kingdom
Estimated trial timing:
July 31, 2020 - March 01, 2023
Cannabidiol and Management of Endometriosis Pain
The investigators are looking to conduct a study looking at the effects of cannabidiol (CBD) in patients with endometriosis. It is believed that CB...
Sponsored by:
Milton S. Hershey Medical Center
Trial Location:
Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania 17033, United States
Estimated trial timing:
December 04, 2020 - June 01, 2023
Trial With BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Anti-PD-1-refractory/Relapsed, Unresectable Stage III or IV Me...
This is an open-label, randomized, multi-site, Phase II, interventional trial designed to evaluate the efficacy, tolerability, and safety of BNT111...
Sponsored by:
BioNTech SE
Trial Location:
Hospital Clinic de Barcelona, Barcelona, 08036, Spain
Estimated trial timing:
May 19, 2021 - June 01, 2025
Effects of Low FODMAP Diet on Leaky Gut
The pathophysiology of Irritable bowel syndrome (IBS) is multifactorial involving complex interplay of altered intestinal permeability, mucosal imm...
Sponsored by:
Beth Israel Deaconess Medical Center
Trial Location:
Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, United States
Estimated trial timing:
May 20, 2019 - December 01, 2021
Detecting SARS-CoV-2 in Tears
Purpose: To determine the presence of SARS-CoV-2 in tears To determine SARS-CoV-2 receptors in tear production system
Sponsored by:
University of Minnesota
Trial Location:
University of Minnesota, Minneapolis, Minnesota 55455, United States
Estimated trial timing:
September 01, 2021 - December 30, 2021
Study to Evaluate Discontinuation and Re-Treatment in Participants With Tenosynovial Giant Cell Tumor (TGCT) Previously Treated With Pexidartinib
This study is designed to evaluate the discontinuation/re-treatment of pexidartinib therapy in previously treated participants with tenosynovial gi...
Sponsored by:
Daiichi Sankyo, Inc.
Trial Location:
Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States
Estimated trial timing:
October 20, 2020 - April 18, 2024
Master Protocol to Assess Safety and Dose of First Time in Human Next Generation Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Advanced So...
This trial will evaluate the safety and efficacy of first time in human engineered T-cell therapies, in participants with advanced tumors.
Sponsored by:
GlaxoSmithKline
Trial Location:
GSK Investigational Site, Toronto, Ontario M5G 2M9, Canada
Estimated trial timing:
December 21, 2020 - February 13, 2024
Evaluation of the 24/7 EEG SubQ System for Ultra Long-Term Recording of Patients With Temporal Lobe Epilepsy
The 24/7 EEG™ SubQ system will be compared to simultaneously recorded video-EEG in the Epilepsy Monitoring Unit (gold standard) and to self-reporte...
Sponsored by:
UNEEG Medical A/S
Trial Location:
Mayo Clinic, Phoenix, Arizona 85054, United States
Estimated trial timing:
April 21, 2021 - August 30, 2023
Development of Validated Bruise Scale in HNV
Subjects will have a mechanically induced bruise photographed over a period of 11 days to record the healing process. Assessors will rate the bruis...
Sponsored by:
Cearna, Inc.
Trial Location:
Artemis Clinical Research, San Diego, California 92109, United States
Estimated trial timing:
September 25, 2020 - April 28, 2021
A Study to Assess the Safety, Tolerability and Immunogenicity of ASP3772, a Pneumococcal Vaccine, in Toddlers 12 to 15 Months of Age in Comparison ...
The purpose of this study is to evaluate the safety and tolerability of three dose levels of ASP3772 in comparison to the active comparator Prevnar...
Sponsored by:
Affinivax, Inc.
Trial Location:
Dermatology Trial Associates, Bryant, Arkansas 72022, United States
Estimated trial timing:
September 22, 2020 - April 06, 2022
Effects of a Red/Gold/IR LED Combination Light on Reduction of Fat
An open-label evaluation of the effects of a red/gold/IR LED combination light on reduction of fat. The results shall be compared to previous resul...
Sponsored by:
Ward Photonics LLC
Trial Location:
Horizon Medical Center, Schaumburg, Illinois 60173, United States
Estimated trial timing:
August 07, 2020 - December 31, 2021
Feasibility Trial of Narrative Exposure Therapy (NET) for Posttraumatic Stress Disorder (PTSD) During Pregnancy
Posttraumatic stress disorder (PTSD) affects up to 35% of pregnant trauma survivors. Moreover, prenatal PTSD rates are up to 4 times higher among c...
Sponsored by:
Rush University Medical Center
Trial Location:
Rush University Medical Center, Chicago, Illinois 60612, United States
Estimated trial timing:
February 27, 2019 - May 01, 2022
Study of Descartes-30 in Acute Respiratory Distress Syndrome
Emergency study to test the safety of Descartes-30 cells in patients with moderate-to-severe acute respiratory distress syndrome (ARDS) AND COVID-19
Sponsored by:
Cartesian Therapeutics
Trial Location:
Brigham and Women's Hospital, Boston, Massachusetts 02115, United States
Estimated trial timing:
February 23, 2021 - September 25, 2022
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus...
This is a Phase Ib/II, open-label, multicenter, randomized umbrella study in participants with advanced liver cancers. The study is designed with t...
Sponsored by:
Hoffmann-La Roche
Trial Location:
Seoul National University Hospital, Seoul, 03080, Korea, Republic of
Estimated trial timing:
November 02, 2020 - July 10, 2025
Depression Screening in Black Churches
The overall aim of this study is to employ Community Health Workers (CHWs) to screen for depression in 30 Black churches and compare the effectiven...
Sponsored by:
Columbia University
Trial Location:
Columbia University Irving Medical Center Center, New York, New York 10027, United States
Estimated trial timing:
August 01, 2021 - May 31, 2025
Our website uses cookies, as almost all websites do, to help provide you with the best experience we can. You can learn more about all the cookies and the information we collect by reading our Privacy Policy.
